| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.491 | 0.016 | 0.5 | Hypoglycemic | 0.5 0.015 DBMET01821 0.468 0.018 DBMET00205 0.5 0.015 DBMET00206 | DBMET00206 | |
| 0.323 | 0.01 | 0.323 | Insulin secretagoues | 0.32 0.01 DBMET01821 0.298 0.013 DBMET00205 0.32 0.01 DBMET00206 | ||
| 0.303 | 0.022 | 0.304 | Diuretic | 0.284 0.025 DBMET01821 0.304 0.022 DBMET00205 0.284 0.025 DBMET00206 | DBMET00205 | |
| 0.301 | 0.052 | 0.319 | Platelet antagonist | 0.319 0.047 DBMET01821 0.307 0.05 DBMET00205 0.319 0.047 DBMET00206 | DBMET00206 | |
| 0.298 | 0.057 | 0.34 | Cardiotonic | 0.34 0.042 DBMET01821 0.312 0.051 DBMET00205 0.34 0.042 DBMET00206 | DBMET00206 | |
| 0.355 | 0.118 | 0.439 | Cyclophilin D inhibitor | 0.439 0.072 DBMET01821 0.416 0.082 DBMET00205 0.439 0.072 DBMET00206 | DBMET00206 | |
| 0.273 | 0.056 | 0.273 | Potassium channel blocker | 0.181 0.106 DBMET01821 0.184 0.104 DBMET00205 0.181 0.106 DBMET00206 | ||
| 0.197 | 0.004 | 0.197 | Potassium channel (ATP-sensitive) blocker | 0.156 0.005 DBMET01821 0.136 0.006 DBMET00205 0.156 0.005 DBMET00206 | ||
| 0.313 | 0.129 | 0.313 | Beta lactamase inhibitor | |||
| 0.261 | 0.099 | 0.261 | Nootropic | 0.22 0.134 DBMET01821 0.184 0.18 DBMET00205 0.22 0.134 DBMET00206 | ||
| 0.17 | 0.011 | 0.17 | Carbonic anhydrase V inhibitor | 0.122 0.021 DBMET01821 0.084 0.033 DBMET00205 0.122 0.021 DBMET00206 | ||
| 0.163 | 0.008 | 0.163 | Carbonic anhydrase VA inhibitor | 0.124 0.017 DBMET01821 0.096 0.027 DBMET00205 0.124 0.017 DBMET00206 | ||
| 0.161 | 0.01 | 0.161 | Carbonic anhydrase stimulant | 0.094 0.02 DBMET01821 0.076 0.028 DBMET00205 0.094 0.02 DBMET00206 | ||
| 0.154 | 0.004 | 0.154 | Bombesin 3 receptor antagonist | 0.139 0.004 DBMET01821 0.136 0.005 DBMET00205 0.139 0.004 DBMET00206 | ||
| 0.224 | 0.09 | 0.224 | Calpain inhibitor | |||
| 0.149 | 0.015 | 0.149 | Cannabinoid receptor antagonist | 0.064 0.057 DBMET00205 | ||
| 0.151 | 0.032 | 0.151 | Chemokine receptor antagonist | 0.096 0.067 DBMET01821 0.091 0.073 DBMET00205 0.096 0.067 DBMET00206 | ||
| 0.161 | 0.05 | 0.161 | Sodium channel blocker | |||
| 0.108 | 0.004 | 0.108 | Carbonic anhydrase I stimulant | 0.089 0.005 DBMET01821 0.084 0.006 DBMET00205 0.089 0.005 DBMET00206 | ||
| 0.199 | 0.096 | 0.199 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.225 | 0.123 | 0.225 | Insulysin inhibitor | |||
| 0.111 | 0.013 | 0.111 | Cannabinoid CB1 receptor antagonist | 0.056 0.05 DBMET00205 | ||
| 0.246 | 0.152 | 0.246 | Calpain 2 inhibitor | |||
| 0.099 | 0.005 | 0.099 | Carbonic anhydrase II stimulant | 0.083 0.008 DBMET01821 0.079 0.009 DBMET00205 0.083 0.008 DBMET00206 | ||
| 0.106 | 0.017 | 0.106 | Potassium channel Kv1.5 blocker | 0.098 0.019 DBMET01821 0.086 0.023 DBMET00205 0.098 0.019 DBMET00206 | ||
| 0.1 | 0.011 | 0.1 | Thromboxane antagonist | 0.095 0.013 DBMET01821 0.086 0.017 DBMET00205 0.095 0.013 DBMET00206 | ||
| 0.118 | 0.03 | 0.118 | Neuropeptide Y antagonist | |||
| 0.102 | 0.018 | 0.102 | Carbonic anhydrase I inhibitor | 0.1 0.018 DBMET01821 0.069 0.029 DBMET00205 0.1 0.018 DBMET00206 | ||
| 0.106 | 0.022 | 0.106 | Epoxide hydrolase inhibitor | 0.086 0.036 DBMET01821 0.095 0.028 DBMET00205 0.086 0.036 DBMET00206 | ||
| 0.096 | 0.012 | 0.096 | Carbonic anhydrase XIV inhibitor | 0.083 0.016 DBMET01821 0.06 0.024 DBMET00205 0.083 0.016 DBMET00206 | ||
| 0.093 | 0.009 | 0.093 | Thromboxane A2 antagonist | 0.088 0.011 DBMET01821 0.082 0.014 DBMET00205 0.088 0.011 DBMET00206 | ||
| 0.088 | 0.01 | 0.088 | Potassium channel (Inward rectifier) blocker | 0.076 0.014 DBMET01821 0.072 0.016 DBMET00205 0.076 0.014 DBMET00206 | ||
| 0.157 | 0.082 | 0.157 | Cyclin-dependent kinase 3 inhibitor | 0.141 0.12 DBMET01821 0.141 0.12 DBMET00206 | ||
| 0.108 | 0.035 | 0.112 | Carbonic anhydrase VI inhibitor | 0.112 0.033 DBMET01821 0.093 0.044 DBMET00205 0.112 0.033 DBMET00206 | DBMET00206 | |
| 0.1 | 0.027 | 0.102 | Carbonic anhydrase inhibitor | 0.102 0.026 DBMET01821 0.063 0.044 DBMET00205 0.102 0.026 DBMET00206 | DBMET00206 | |
| 0.104 | 0.036 | 0.104 | Carbonic anhydrase XIII inhibitor | 0.08 0.05 DBMET01821 0.08 0.05 DBMET00206 | ||
| 0.083 | 0.016 | 0.083 | Beta 1 adrenoreceptor antagonist | 0.076 0.021 DBMET01821 0.066 0.029 DBMET00205 0.076 0.021 DBMET00206 | ||
| 0.075 | 0.015 | 0.075 | Thromboxane synthase inhibitor | 0.059 0.029 DBMET01821 0.061 0.025 DBMET00205 0.059 0.029 DBMET00206 | ||
| 0.083 | 0.024 | 0.088 | Carbonic anhydrase II inhibitor | 0.088 0.022 DBMET01821 0.058 0.036 DBMET00205 0.088 0.022 DBMET00206 | DBMET00206 | |
| 0.098 | 0.039 | 0.098 | Metalloproteinase-2 inhibitor | 0.073 0.06 DBMET01821 0.073 0.06 DBMET00206 | ||
| 0.072 | 0.014 | 0.072 | HCV NS3/NS4A protease inhibitor | 0.06 0.021 DBMET01821 0.062 0.02 DBMET00205 0.06 0.021 DBMET00206 | ||
| 0.086 | 0.033 | 0.086 | CXC chemokine receptor antagonist | |||
| 0.08 | 0.027 | 0.08 | Carbonic anhydrase IX inhibitor | |||
| 0.092 | 0.04 | 0.092 | CC chemokine receptor antagonist | |||
| 0.086 | 0.035 | 0.086 | Thrombin inhibitor | 0.073 0.05 DBMET01821 0.069 0.056 DBMET00205 0.073 0.05 DBMET00206 | ||
| 0.192 | 0.141 | 0.192 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.067 | 0.016 | 0.067 | Carbonic anhydrase VII inhibitor | 0.044 0.035 DBMET01821 0.044 0.035 DBMET00206 | ||
| 0.074 | 0.027 | 0.074 | Carbonic anhydrase XII inhibitor | |||
| 0.077 | 0.034 | 0.077 | Neutrophil collagenase inhibitor | |||
| 0.076 | 0.035 | 0.076 | Bcl2 antagonist | 0.067 0.046 DBMET01821 0.059 0.057 DBMET00205 0.067 0.046 DBMET00206 | ||
| 0.112 | 0.072 | 0.112 | Proteasome inhibitor | |||
| 0.044 | 0.007 | 0.044 | Epoxide hydrolase 2 inhibitor | 0.035 0.011 DBMET01821 0.034 0.012 DBMET00205 0.035 0.011 DBMET00206 | ||
| 0.056 | 0.02 | 0.056 | Collagenase inhibitor | 0.052 0.028 DBMET01821 0.05 0.032 DBMET00205 0.052 0.028 DBMET00206 | ||
| 0.059 | 0.025 | 0.061 | Beta 2 adrenoreceptor antagonist | 0.061 0.023 DBMET01821 0.052 0.033 DBMET00205 0.061 0.023 DBMET00206 | DBMET00206 | |
| 0.274 | 0.24 | 0.4 | Antiinflammatory | 0.4 0.14 DBMET01821 0.38 0.151 DBMET00205 0.4 0.14 DBMET00206 | DBMET00206 | |
| 0.058 | 0.026 | 0.058 | Glycine transporter inhibitor | |||
| 0.124 | 0.095 | 0.124 | CC chemokine 6 receptor antagonist | 0.124 0.097 DBMET01821 0.122 0.105 DBMET00205 0.124 0.097 DBMET00206 | ||
| 0.188 | 0.16 | 0.188 | MAP kinase kinase 3 inhibitor | |||
| 0.129 | 0.101 | 0.129 | Anticoagulant | 0.12 0.112 DBMET01821 0.12 0.112 DBMET00206 | ||
| 0.062 | 0.035 | 0.062 | Bcl-xL inhibitor | 0.057 0.051 DBMET01821 0.057 0.051 DBMET00206 | ||
| 0.065 | 0.039 | 0.065 | Trypsin inhibitor | 0.059 0.049 DBMET01821 0.058 0.055 DBMET00205 0.059 0.049 DBMET00206 | ||
| 0.048 | 0.026 | 0.06 | Carbonic anhydrase IV inhibitor | 0.06 0.019 DBMET01821 0.042 0.031 DBMET00205 0.06 0.019 DBMET00206 | DBMET00206 | |
| 0.027 | 0.005 | 0.027 | Carbonic anhydrase IV stimulant | 0.019 0.007 DBMET01821 0.018 0.008 DBMET00205 0.019 0.007 DBMET00206 | ||
| 0.053 | 0.033 | 0.053 | Prostaglandin E2 antagonist | 0.045 0.041 DBMET01821 0.045 0.041 DBMET00206 | ||
| 0.095 | 0.075 | 0.095 | Carbonic anhydrase XV inhibitor | |||
| 0.047 | 0.027 | 0.047 | Secretase gamma inhibitor | |||
| 0.078 | 0.06 | 0.081 | Adrenaline agonist | 0.081 0.056 DBMET01821 0.081 0.056 DBMET00206 | DBMET00206 | |
| 0.071 | 0.053 | 0.071 | Metalloproteinase-9 inhibitor | |||
| 0.065 | 0.047 | 0.068 | Beta adrenoreceptor antagonist | 0.068 0.042 DBMET01821 0.068 0.042 DBMET00206 | DBMET00206 | |
| 0.045 | 0.027 | 0.045 | CC chemokine 3 receptor antagonist | |||
| 0.065 | 0.048 | 0.065 | Matrix metalloproteinase inhibitor | |||
| 0.039 | 0.023 | 0.039 | Bradykinin antagonist | |||
| 0.059 | 0.043 | 0.059 | Collagenase 3 inhibitor | |||
| 0.025 | 0.011 | 0.025 | Bombesin agonist | |||
| 0.039 | 0.025 | 0.039 | Potassium channel Kv1.1 blocker | |||
| 0.072 | 0.059 | 0.072 | Vanilloid 4 agonist | |||
| 0.021 | 0.01 | 0.021 | Bombesin 3 receptor agonist | |||
| 0.053 | 0.043 | 0.053 | Epithelial sodium channel blocker | |||
| 0.103 | 0.094 | 0.103 | Sphingosine 1-phosphate receptor 2 agonist | 0.102 0.097 DBMET01821 0.102 0.097 DBMET00206 | ||
| 0.078 | 0.07 | 0.078 | Histamine H2 receptor antagonist | |||
| 0.045 | 0.038 | 0.045 | Bombesin antagonist | |||
| 0.228 | 0.221 | 0.228 | MAP kinase kinase 6 inhibitor | |||
| 0.048 | 0.041 | 0.048 | Potassium channel (Inward rectifier) activator | |||
| 0.123 | 0.116 | 0.123 | Neuropeptide Y1 antagonist | |||
| 0.027 | 0.021 | 0.027 | Bradykinin B1 receptor antagonist | |||
| 0.025 | 0.019 | 0.031 | Prostaglandin EP4 antagonist | 0.031 0.014 DBMET01821 0.023 0.022 DBMET00205 0.031 0.014 DBMET00206 | DBMET00206 | |
| 0.037 | 0.031 | 0.037 | Aggrecanase 1 inhibitor | |||
| 0.046 | 0.041 | 0.046 | Neuropeptide Y5 antagonist | |||
| 0.046 | 0.041 | 0.046 | Matrix metalloproteinase 1 inhibitor | |||
| 0.015 | 0.011 | 0.015 | CC chemokine 10 receptor antagonist | |||
| 0.022 | 0.018 | 0.024 | CC chemokine 1 receptor antagonist | 0.021 0.019 DBMET01821 0.024 0.016 DBMET00205 0.021 0.019 DBMET00206 | DBMET00205 | |
| 0.032 | 0.029 | 0.032 | HCV polyprotein inhibitor | 0.032 0.029 DBMET01821 0.032 0.029 DBMET00205 0.032 0.029 DBMET00206 | ||
| 0.045 | 0.042 | 0.045 | Potassium channel (ATP-sensitive) activator | |||
| 0.068 | 0.067 | 0.068 | Somatostatin 1 agonist | |||
| 0.042 | 0.044 | 0.044 | Beta adrenoreceptor agonist | 0.044 0.037 DBMET01821 0.044 0.037 DBMET00206 | DBMET00206 | |
| 0.129 | 0.133 | 0.152 | Platelet adhesion inhibitor | 0.152 0.103 DBMET01821 0.135 0.124 DBMET00205 0.152 0.103 DBMET00206 | DBMET00206 | |
| 0.081 | 0.09 | 0.087 | Carbonic anhydrase III inhibitor | 0.087 0.079 DBMET01821 0.087 0.079 DBMET00206 | DBMET00206 | |
| 0.047 | 0.061 | 0.055 | MAP kinase kinase 9 inhibitor | 0.055 0.04 DBMET01821 0.055 0.04 DBMET00206 | DBMET00206 | |
| 0.031 | 0.05 | 0.042 | Glucose-6-phosphate dehydrogenase inhibitor | 0.042 0.019 DBMET01821 0.04 0.021 DBMET00205 0.042 0.019 DBMET00206 | DBMET00206 | |
| 0.048 | 0.075 | 0.061 | Prostaglandin F2 alpha antagonist | 0.061 0.044 DBMET01821 0.058 0.051 DBMET00205 0.061 0.044 DBMET00206 | DBMET00206 | |
| 0.179 | 0.206 | 0.236 | Antithrombotic | 0.236 0.138 DBMET01821 0.201 0.175 DBMET00205 0.236 0.138 DBMET00206 | DBMET00206 | |
| 0.094 | 0.181 | 0.122 | NOS3 expression enhancer | 0.122 0.111 DBMET01821 0.122 0.111 DBMET00206 | DBMET00206 | |
| 0.033 | 0.127 | 0.061 | Vanilloid 1 antagonist | 0.061 0.054 DBMET00205 | DBMET00205 | |
| 0.045 | 0.146 | 0.094 | MAP kinase kinase 8 inhibitor | 0.064 0.056 DBMET01821 0.094 0.025 DBMET00205 0.064 0.056 DBMET00206 | DBMET00205 | |
| 0.049 | 0.162 | 0.093 | Bronchodilator | 0.093 0.072 DBMET01821 0.086 0.079 DBMET00205 0.093 0.072 DBMET00206 | DBMET00206 | |
| 0.153 | 0.272 | 0.244 | Toll-Like receptor 7 agonist | 0.217 0.181 DBMET01821 0.244 0.153 DBMET00205 0.217 0.181 DBMET00206 | DBMET00205 | |
| 0.151 | 0.274 | 0.242 | Toll-Like receptor agonist | 0.216 0.183 DBMET01821 0.242 0.156 DBMET00205 0.216 0.183 DBMET00206 | DBMET00205 | |
| 0.129 | 0.263 | 0.217 | Peptidyltransferase inhibitor | 0.217 0.079 DBMET01821 0.205 0.093 DBMET00205 0.217 0.079 DBMET00206 | DBMET00206 | |
| 0.016 | 0.252 | 0.033 | Antibiotic Aminoglycoside-like | 0.033 0.031 DBMET00205 | DBMET00205 | |
| 0.112 | 0.353 | 0.281 | Sodium/bile acid cotransporter inhibitor | 0.281 0.096 DBMET01821 0.267 0.11 DBMET00205 0.281 0.096 DBMET00206 | DBMET00206 | |
| 0.003 | 0.65 | 0.027 | 1,3-Beta-glucan synthase inhibitor | 0.027 0.025 DBMET00205 | DBMET00205 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |